首页> 美国卫生研究院文献>Tissue Engineering. Part A >Development and In Vivo Evaluation of Small-Diameter Vascular Grafts Engineered by Outgrowth Endothelial Cells and Electrospun Chitosan/Poly(ɛ-Caprolactone) Nanofibrous Scaffolds
【2h】

Development and In Vivo Evaluation of Small-Diameter Vascular Grafts Engineered by Outgrowth Endothelial Cells and Electrospun Chitosan/Poly(ɛ-Caprolactone) Nanofibrous Scaffolds

机译:内皮细胞和静电纺丝壳聚糖/聚(ε-己内酯)纳米纤维支架构建的小直径血管移植物的开发和体内评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Successful engineering of a small-diameter vascular graft is still a challenge despite numerous attempts for decades. The present study aimed at developing a tissue-engineered vascular graft (TEVG) using autologous outgrowth endothelial cells (OECs) and a hybrid biodegradable polymer scaffold. OECs were harvested from canine peripheral blood and proliferated in vitro, as well as identified by immunofluorescent staining. Electrospun hybrid chitosan/poly(ɛ-caprolactone) (CS/PCL) nanofibers were fabricated and served as vascular scaffolds. TEVGs were constructed in vitro by seeding OECs onto CS/PCL scaffolds, and then implanted into carotid arteries of cell-donor dogs (n=6). After 3 months of implantation, 5 out of 6 of TEVGs remained patent as compared with 1 out of 6 of unseeded grafts kept patent. Histological and immunohistochemical analyses of the TEVGs retrieved at 3 months revealed the regeneration of endothelium, and the presence of collagen and elastin. OECs labeled with fluorescent dye before implantation were detected in the retrieved TEVGs, indicating that the OECs participated in the vascular tissue regeneration. Biomechanical testing of TEVGs showed good mechanical properties that were closer to native carotid arteries. RT-PCR and western blot analysis demonstrated that TEVGs had favorable biological functional properties resembling native arteries. Overall, this study provided a new strategy to develop small-diameter TEVGs with excellent biocompatibility and regeneration ability.
机译:尽管数十年来进行了多次尝试,但成功设计小直径血管移植物仍然是一个挑战。本研究旨在利用自体生长内皮细胞(OEC)和可生物降解的聚合物混合支架开发组织工程化的血管移植物(TEVG)。从犬外周血中收集OEC,并在体外增殖,并通过免疫荧光染色进行鉴定。制备了静电纺丝的壳聚糖/聚(ε-己内酯)杂化(CS / PCL)纳米纤维,并用作血管支架。通过将OEC植入CS / PCL支架上体外构建TEVG,然后将其植入细胞供体犬(n = 6)的颈动脉中。植入3个月后,六分之六的TEVG保持专利,而六分之六的未播种移植物保持专利。对3个月后取回的TEVG的组织学和免疫组化分析显示,内皮细胞再生,并且胶原蛋白和弹性蛋白存在。在回收的TEVG中检测到植入前用荧光染料标记的OEC,这表明OEC参与了血管组织的再生。 TEVG的生物力学测试显示出良好的机械性能,其更接近于天然颈动脉。 RT-PCR和蛋白质印迹分析表明,TEVG具有类似于天然动脉的良好生物学功能。总的来说,这项研究为开发具有出色生物相容性和再生能力的小直径TEVG提供了新的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号